Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim J Crook

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Drugs in Dermatology : JDD|February 28, 2019
Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label StudyPhoebe Rich, Mary Spellman, Vivek Purohit, et al.
Journal of Endourology|December 22, 2007
Totally tubeless percutaneous nephrolithotomyTim J Crook, C R Lockyer, Stephen R Keoghane, et al.
Scandinavian Journal of Urology and Nephrology|March 8, 2003
A case of amyloid of the urethra and review of this rare diagnosis, its natural history and management, with reference to the literatureTim J Crook, Matthias Koslowski, Jon P Dyer, et al.
The Journal of Urology|November 19, 2015
Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic SyndromesJ Curtis Nickel, Ian W Mills, Tim J Crook, et al.
Journal of Pediatric Urology|March 16, 2012
Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladderBimal Malhotra, Ahmed El-Tahtawy, Ellen Q Wang, et al.
Urology|September 27, 2012
Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndromeJ Curtis Nickel, Gary Atkinson, John N Krieger, et al.
Journal of Pediatric Urology|December 12, 2022
Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 studyTakeya Kitta, Amanda Darekar, Bimal Malhotra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Drugs in Dermatology : JDD|February 28, 2019
Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label StudyPhoebe Rich, Mary Spellman, Vivek Purohit, et al.
Journal of Endourology|December 22, 2007
Totally tubeless percutaneous nephrolithotomyTim J Crook, C R Lockyer, Stephen R Keoghane, et al.
Scandinavian Journal of Urology and Nephrology|March 8, 2003
A case of amyloid of the urethra and review of this rare diagnosis, its natural history and management, with reference to the literatureTim J Crook, Matthias Koslowski, Jon P Dyer, et al.
The Journal of Urology|November 19, 2015
Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic SyndromesJ Curtis Nickel, Ian W Mills, Tim J Crook, et al.
Journal of Pediatric Urology|March 16, 2012
Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladderBimal Malhotra, Ahmed El-Tahtawy, Ellen Q Wang, et al.
Urology|September 27, 2012
Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndromeJ Curtis Nickel, Gary Atkinson, John N Krieger, et al.
Journal of Pediatric Urology|December 12, 2022
Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 studyTakeya Kitta, Amanda Darekar, Bimal Malhotra, et al.
Pageof 1